/biz/ - Business & Finance

>>57639994
Fundamentals look strong though and forward p/e is like 2.5 based on below. I think it could be valued in the $12-15 range after the next earnings report
>SIGA’s third quarter and year-to-date financial results reflect a relatively minor percentage of full year target revenues ... under the third quarter BARDA contract order, have recently started and we are targeting the delivery of approximately $113 million of oral TPOXX to the stockpile in the fourth quarter. Additionally, in the fourth quarter, we are targeting $15 million - $18 million of international deliveries of oral TPOXX, as well as the delivery of approximately $5 million of oral TPOXX to the U.S. Department of Defense and deliveries of up to $15 million of IV TPOXX to the strategic national stockpile. Based on these delivery targets, we are targeting full year 2023 pre-tax operating income of between $90 million and $100 million